Oral anticoagulants: Mixing new with the old
Pharmacists in community-based practice.
Universal program number: 0401-0000-16-010-H01-P
CEBroker tracking number: 20-583774
Activity type: Knowledge-based
To update knowledge of the role of new oral anticoagulants as compared with warfarin.
With four new oral anticoagulants approved over the last decade, selection of an appropriate agent has become significantly more difficult. Community pharmacists need to be aware of not only appropriate indications, but also common serious potential adverse effects of each of the agents in order to make the appropriate interventions. This lesson will review these topics and provide an overview of clinical information that can be applied in practice.
Upon completion of this program, the pharmacist should be able to:
- Describe appropriate indications for oral anticoagulants.
- Identify common adverse effects of oral anticoagulants.
- Review serious potential adverse effects of oral anticoagulants.
- List cost differences among available anticoagulant therapies.
- Describe key counseling and therapy monitoring aspects needed with oral anticoagulant therapy.
To obtain credit:
A minimum test score of 70% is needed to obtain credit. Submit your answers to the learning assessment questions online at DrugStoreNewsCE.com. Your statement of credit will be available through CPE Monitor located at NABP.net. To ensure transmission of credit hours to CPE Monitor, you must enter your correct e-PID number in your CE profile.
If you have a question, visit our Frequently Asked Questions page.
All other customer service questions should be directed to DRSNCE@lf1925.com.
Drug Store News is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This CPE activity is approved for pharmacists and is worth 2.0 contact hours (0.2 CEUs). The activity is available for CE credit through Dec. 9, 2019.
Jon P. Wietholter, PharmD, BCPS, Clinical Associate Professor, WVU School of Pharmacy, Internal Medicine Clinical Pharmacist, WVU-Medicine Ruby Memorial Hospital
Jon P. Wietholter and the DSN editorial and continuing education staff do not have any actual or potential conflicts of interest in relation to this lesson.
- 2.00 Pharmacist